Back to Screener

Basic Materials

Chemours Co.(CC)

Live Price

Offline

$20.74

-2.90% today

1Y Change

+80.87%

Window

Jun 30, 2025 โ†’ Jun 26, 2026

Market Cap
$4.19B
Revenue Growth
+0.4%
EPS Growth
-543.1%
Dividend Yield
1.3%

Coverage: 249 bars ยท Jun 30, 2025 โ†’ Jun 26, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Chemours Co. (CC) is a Basic Materials stock with a market cap of $4.19B and listed on NYSE. The stock last traded around $20.74 and up 80.9% across the available one-year price window (Jun 30, 2025 โ†’ Jun 26, 2026). Baseline metrics include revenue growth of +0.4%, EPS growth of -543.1%, a dividend yield of 1.3%. What stands out right now is revenue +0.4%, EPS -543.1%, free cash flow +105.1% with operating margin -0.8% and ROIC -0.8%. The dividend is present but secondary, with a yield around 1.3%. Valuation is more restrained than many high-expectation growth names at price/sales 0.7. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines CC price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Basic Materials peers on this page.

Benchmark Edge

CC vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

Relative Read

Mixed setup vs SPY

CC is 62.89 pts ahead over the shared 1Y window.

CC had 31.08 pts deeper max drawdown than SPY.

CC beat SPY in 1 of 2 calendar years shown and trailed in 1.

CC

+80.87%

Normalized return

SPY

+17.99%

S&P 500

Excess Return

+62.89 pts

Relative to SPY

CC Max Drawdown

-40.22%

Trailing 1Y

SPY Max Drawdown

-9.13%

Trailing 1Y

CCSPY

Calendar-Year Returns

Uses the longest available daily history for CC and SPY.

YearCCSPYExcessLeader
2026+69.06%+6.71%+62.35 ptsCC
2025+3.23%+11.19%-7.96 ptsSPY

Financial profile

Chemours Co. (CC)

Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.

FY Revenue

$6.3B

-7.1% YoY

FY Net Income

$608.0M

+5.2% YoY

Free Cash Flow

$537.0M

+19.9% YoY

Revenue Growth

+0.4%

EPS Growth

-543.1%

Gross Margin

15.1%

Net Margin

-7.1%

Income statement

USD

Annual
Metric20252024202320222021
Revenue5.8B5.8B6.1B6.8B6.3B
Gross Profit902M1.2B1.3B1.6B1.4B
Operating Income-5M443M-123M786M674M
EBITDA332M692M197M1.2B1.2B
Net Income-386M86M-238M578M608M
EPS (Diluted)โ€”โ€”โ€”โ€”โ€”

Balance sheet

USD

Point-in-time
Metric20252024202320222021
Cash & Equivalents672M713M1.2B1.1B1.5B
Total Assets7.4B7.5B8.3B7.6B7.5B
Total Liabilities7.1B6.9B7.5B6.5B6.5B
Shareholder Equity250M604M737M1.1B1.1B
Total Debt4.6B4.4B4.3B3.9B4.0B
Net Debt3.9B3.6B3.1B2.8B2.5B

Cash flow positioning

Latest Full Year

Operating Cash Flow

814M

+7.8% YoY

Capital Expenditures

277M

+9.8% YoY

Free Cash Flow

537M

+19.9% YoY

Key ratios

  • Gross Margin

    15.1%

  • Operating Margin

    -0.8%

  • Net Margin

    -7.1%

  • ROE

    -164.4%

  • Debt / Equity

    1.07x

Next Step

Turn financials into a decision

Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.